Submitted by Anonymous (not verified) on 24 October 2024 - 15:01
Pharmacovigilance Risk Assessment Committee (PRAC): 23 - 26 November 2026, European Medicines Agency, Amsterdam, the Netherlands, from 23 November 2026 to 26 November 2026
Source: